Clearmind Medicine Inc
CNSX:CMND
Cash Flow Statement
Cash Flow Statement
Clearmind Medicine Inc
| Jan-2021 | Apr-2021 | Jul-2021 | Oct-2021 | Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
(0)
|
(0)
|
(1)
|
(3)
|
(6)
|
(9)
|
(10)
|
(7)
|
(7)
|
(6)
|
(4)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
2
|
2
|
2
|
0
|
3
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
1
|
(0)
|
1
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(1)
-126%
|
(1)
-42%
|
(2)
-83%
|
(5)
-115%
|
(7)
-46%
|
(7)
+1%
|
(4)
+43%
|
(5)
-36%
|
(4)
+30%
|
(5)
-28%
|
(6)
-38%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-3 559%
|
0
N/A
|
(0)
N/A
|
(0)
-29%
|
(0)
+98%
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
2
|
7
|
5
|
0
|
7
|
2
|
1
|
7
|
9
|
9
|
12
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
2
N/A
|
7
+326%
|
5
-26%
|
0
N/A
|
6
N/A
|
1
-88%
|
1
-35%
|
7
+1 215%
|
9
+33%
|
9
+0%
|
12
+30%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
0
N/A
|
1
+286%
|
6
+580%
|
3
-49%
|
3
-18%
|
(0)
N/A
|
(6)
-1 584%
|
(3)
+47%
|
2
N/A
|
5
+231%
|
4
-17%
|
5
+19%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(0)
N/A
|
(1)
-129%
|
(1)
-42%
|
(2)
-84%
|
(5)
-113%
|
(7)
-47%
|
(7)
+1%
|
(4)
+44%
|
(5)
-36%
|
(4)
+30%
|
(5)
-28%
|
(6)
-38%
|
|